CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 139 enrolled
Drug / intervention
Placebo sugar pill +1 moredrug
Likely dose
Ergocalciferol 50,000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01426347
NCT01426347N/ACompleted
CompareCT.gov

Vitamin Therapy in Rheumatoid Arthritis

Johns Hopkins University·interventional·Posted Aug 31, 2011·Updated Mar 20, 2017

In Brief

A clinical study evaluating Placebo sugar pill and Ergocalciferol for Rheumatoid Arthritis and Vitamin D Deficiency. Completed, enrolled 139 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the effect of vitamin D repletion on disease activity and disability in patients with rheumatoid arthritis. The investigators hypothesize that rheumatoid arthritis (RA) patients with vitamin D deficiency have greater disease activity and disability, compared to RA patients with normal vitamin D levels. The investigators also hypothesize that vitamin D treatment in these deficient patients will result in a decrease in RA disease activity and disability.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis, Vitamin D Deficiency
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 31, 2011
Enrollment StartJan 1, 2009
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 14.8 years ago

Interventions

Placebo sugar pilldrug

Intervention includes 1 sugar pill once a week for 16 weeks dispensed as a capsule.

Ergocalciferoldrug

Ergocalciferol 50,000 IU per week for 16 weeks